Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study
NCT07523971
·
clinicaltrials.gov ↗
RECRUITING
Status
10000
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemias
Sponsor
JW Pharmaceutical